Sweet syndrome, also known as acute febrile neutrophilic dermatosis, is characterized by sudden onset of painful red lesions, often accompanied by fever and elevated white blood cell counts. It is typically associated with infections, certain cancers, or medications such as antibiotics and vaccines. However, cases linked to inhaled therapies have not been previously documented, making this situation particularly noteworthy.
This case highlights the importance of vigilance when introducing even commonly used medications. For healthcare providers, recognizing unusual symptoms following treatment changes can be critical for early diagnosis and effective care. It also serves as a reminder that even well-established therapies can carry rare and unexpected risks, underscoring the need for awareness, monitoring, and timely medical evaluation.
read more in next page
